From: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy
PBMC/mL of blood
Ratio
Mean ± St.dev (× 106)
Before DOX
1.24 ± 0.67
–
After DOX
0.53 ± 0.15
0.48 ± 0.15